ASTERIAS BIOTHERAPEUTICS INC's ticker is ASTWS and the CUSIP is 04624N115. A total of 35 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 328,205 | $140,000 | 0.03% |
| Manatuck Hill Partners, LLC | 75,000 | $32,000 | 0.01% |
| CSS LLC/IL | 108,542 | $46,000 | 0.00% |
| JPMORGAN CHASE & CO | 264 | $0 | 0.00% |
| ROYAL BANK OF CANADA | 8 | $0 | 0.00% |
| Creative Planning | 131 | $0 | 0.00% |
| VANGUARD GROUP INC | 89,777 | $39,000 | 0.00% |
| Chicago Partners Investment Group LLC | 3 | $0 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 142 | $0 | 0.00% |
| UBS Group AG | 1,255 | $0 | 0.00% |